Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants - Université de La Réunion Access content directly
Journal Articles Acta Paediatrica Year : 2024

Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants

Abstract

Abstract Aim Transcatheter closure of the patent ductus arteriosus (TCPDA) is increasingly used in preterm infants as an alternative to surgical ligation. However, clinically ill preterm infants are at risk of contrast nephropathy due to the angiography contrast agents used during the procedure. Methods We performed a single‐centre before‐and‐after comparative study in VLBW infants to compare the kinetics of serum creatinine during the first 4 days after TCPDA with or without angiography. Results 69 patients were included and divided into two groups: TCPDA with (contrast+; n = 37) and without (contrast−, n = 32) use of contrast agent. The median dose [range] of contrast agent was 1.0 mL/kg [0.6–2.4 mL/kg]. The change in serum creatinine level between day 2 to 4 after TCPCA and baseline decreased in the contrast‐ group (−17% [−46%; 18%]), while it increased in the contrast+ group (7% [−24%; 202%] p = 0.002). Comparison of blood urea levels between groups showed similar significant differences. The change in serum creatinine between day 2 to 4 and baseline was significantly correlated with the dose of contrast agent ( r 2 = 0.682; p < 0.001). Conclusion The use of contrast agents during TCPDA can potentially harm the renal function of very preterm infants. Therefore, we advise minimising or avoiding the use of contrast agents.
No file

Dates and versions

hal-04458372 , version 1 (14-02-2024)

Identifiers

Cite

Chiara Lembo, Mathilde Méot, Kelly Mellul, Annahita Aryafar, Isabelle Szézépanski, et al.. Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants. Acta Paediatrica, 2024, ⟨10.1111/apa.17101⟩. ⟨hal-04458372⟩
6 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More